Progenics Pharmaceuticals, Inc. - Investor Relations

Investor Relations

The investor pages that follow are your resource for financial information about Progenics Pharmaceuticals, Inc.. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.

Corporate Presentation

Recent Releases

Aug 31, 2010
Progenics Pharmaceuticals to Present Preclinical Study of Novel Monoclonal Antibodies Against C. difficile at 2010 ICAAC

Aug 9, 2010
Progenics Pharmaceuticals Announces Second Quarter 2010 Financial Results

Aug 5, 2010
Progenics Announces Positive Opinion Issued by a Committee of the European Medicines Agency for Relistor in Pre-Filled Syringes

Events

Aug 5, 2010
BMO 10th Annual Focus on Healthcare Conference

Jun 9, 2010
Needham Healthcare Conference